Replies to post #99844 on Biotech Values

[biomaven0]

There is no specific legislation I know of related to at-risk drug launches that protects against TROs.

Every now and then a company in fact succeeds in getting a TRO against an at-risk launch - a good example is AZN got a TRO to halt Teva's at-risk launch of Pulmicort.

Here's a powerpoint discussing legal issues surrounding at-risk launches:

http://www.google.com/url?sa=t&source=web&cd=1&ved=0CBYQFjAA&url=http%3A%2F%2Fwww.fr.com%2Ffiles%2Fuploads%2Fpublications%2Fpharmaipsummit%2FHough_Siem-At-Risk_Launch_Slide_Deck.pdf&ei=FwNPTKSuOI28sQPqprCWBw&usg=AFQjCNGheco0BCYB9ng7gzOuEzyQ-ldlzA&sig2=bb0os9inlg6ISQmd2v5NOw